168 related articles for article (PubMed ID: 31038590)
1. In properly selected patients with differentiated thyroid cancer, antithyroglobulin antibodies decline after thyroidectomy and their sole presence should not be an indication for radioiodine ablation.
Zavala LF; Barra MI; Olmos R; Tuttle M; González H; Droppelmann N; Mosso L; Domínguez JM
Arch Endocrinol Metab; 2019; 63(3):293-299. PubMed ID: 31038590
[TBL] [Abstract][Full Text] [Related]
2. Antithyroglobulin Antibody Variation During Follow-Up Has a Good Prognostic Value for Preoperative Antithyroglobulin Antibody-Positive Differentiated Thyroid Cancer Patients: A Retrospective Study in Southwest China.
Liu Q; Yin M; Li G
Front Endocrinol (Lausanne); 2021; 12():774275. PubMed ID: 34975751
[TBL] [Abstract][Full Text] [Related]
3. Indication for radioactive iodine in patients with papillary thyroid carcinoma without apparent disease after total thyroidectomy but with elevated antithyroglobulin antibodies.
Ramos da Silva F; Rosario PW; Mourão GF
Clin Endocrinol (Oxf); 2022 Jan; 96(1):82-88. PubMed ID: 34323308
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Antithyroglobulin Antibody Concentrations Before and After Ablation with 131I as a Predictor of Structural Disease in Differentiated Thyroid Carcinoma Patients with Undetectable Basal Thyroglobulin and Negative Neck Ultrasonography.
Rosario PW; Carvalho M; Mourão GF; Calsolari MR
Thyroid; 2016 Apr; 26(4):525-31. PubMed ID: 26831821
[TBL] [Abstract][Full Text] [Related]
5. Investigating Antithyroglobulin Antibody As a Prognostic Marker for Differentiated Thyroid Cancer: A Meta-Analysis and Systematic Review.
Lee ZJO; Eslick GD; Edirimanne S
Thyroid; 2020 Nov; 30(11):1601-1612. PubMed ID: 32345152
[No Abstract] [Full Text] [Related]
6. Clinical significance of elevated level of serum antithyroglobulin antibody in patients with differentiated thyroid cancer after thyroid ablation.
Chung JK; Park YJ; Kim TY; So Y; Kim SK; Park DJ; Lee DS; Lee MC; Cho BY
Clin Endocrinol (Oxf); 2002 Aug; 57(2):215-21. PubMed ID: 12153600
[TBL] [Abstract][Full Text] [Related]
7. Clinical Impact of Detectable Antithyroglobulin Antibodies Below the Reference Limit (Borderline) in Patients with Papillary Thyroid Carcinoma with Undetectable Serum Thyroglobulin and Normal Neck Ultrasonography After Ablation: A Prospective Study.
Côrtes MCS; Rosario PW; Oliveira LFF; Calsolari MR
Thyroid; 2018 Feb; 28(2):229-235. PubMed ID: 29325506
[TBL] [Abstract][Full Text] [Related]
8. Changing Trend of Thyroglobulin Antibodies in Patients With Differentiated Thyroid Cancer Treated With Total Thyroidectomy Without
Matrone A; Latrofa F; Torregrossa L; Piaggi P; Gambale C; Faranda A; Ricci D; Agate L; Molinaro E; Basolo F; Vitti P; Elisei R
Thyroid; 2018 Jul; 28(7):871-879. PubMed ID: 29860933
[TBL] [Abstract][Full Text] [Related]
9. Predicting clinical outcomes of patients with serum thyroglobulin antibodies after thyroidectomy for differentiated thyroid cancer: a retrospective study from a UK regional center.
Anderson H; Lim KH; Gull S; Oprean R; Spence K; Cvasciuc T
Minerva Endocrinol (Torino); 2024 Mar; 49(1):60-68. PubMed ID: 37428110
[TBL] [Abstract][Full Text] [Related]
10. Outcomes after radioiodine ablation in patients with thyroid cancer: Long-term follow-up of a Chinese randomized clinicaltrial.
Dong P; Qu Y; Yang L; Xiao L; Huang R; Li L
Clin Endocrinol (Oxf); 2021 Nov; 95(5):782-789. PubMed ID: 34368999
[TBL] [Abstract][Full Text] [Related]
11. Individualized Follow-Up Strategy for Patients with an Indeterminate Response to Initial Therapy for Papillary Thyroid Carcinoma.
Oh HS; Ahn JH; Song E; Han JM; Kim WG; Kim TY; Kim WB; Shong YK; Jeon MJ
Thyroid; 2019 Feb; 29(2):209-215. PubMed ID: 30384812
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value and dynamics of antithyroglobulin antibodies for differentiated thyroid carcinoma.
Sun D; Zheng X; He X; Huang C; Jia Q; Tan J; Zheng W; Li N; Wang P; Wang R; Liu M; Zhao L; Yuan S; Meng Z; Fan Y
Biomark Med; 2020 Dec; 14(18):1683-1692. PubMed ID: 33346697
[No Abstract] [Full Text] [Related]
13. Development and clinical impact of thyroglobulin antibodies in patients with differentiated thyroid carcinoma during the first 3 years after thyroidectomy.
Görges R; Maniecki M; Jentzen W; Sheu SN; Mann K; Bockisch A; Janssen OE
Eur J Endocrinol; 2005 Jul; 153(1):49-55. PubMed ID: 15994745
[TBL] [Abstract][Full Text] [Related]
14. Age, thyroglobulin levels and ATA risk stratification predict 10-year survival rate of differentiated thyroid cancer patients.
Kelly A; Barres B; Kwiatkowski F; Batisse-Lignier M; Aubert B; Valla C; Somda F; Cachin F; Tauveron I; Maqdasy S
PLoS One; 2019; 14(8):e0221298. PubMed ID: 31425569
[TBL] [Abstract][Full Text] [Related]
15. Monitoring differentiated thyroid cancer patients with negative serum thyroglobulin. Diagnostic implication of TSH-stimulated antithyroglobulin antibody.
Nam HY; Paeng JC; Chung JK; Kang KW; Cheon GJ; Kim Y; Park DJ; Park YJ; Min HS; Lee DS
Nuklearmedizin; 2014; 53(2):32-8. PubMed ID: 24276613
[TBL] [Abstract][Full Text] [Related]
16. Thyroglobulin antibodies: Trend over time and clinical impact in differentiated thyroid carcinoma with and without radioiodine ablation.
Iglesias ML; Calabretta JM; Coggiola O; Califano I
Endocrinol Diabetes Nutr (Engl Ed); 2022 Nov; 69(9):702-708. PubMed ID: 36470645
[TBL] [Abstract][Full Text] [Related]
17. The follow-up of patients with differentiated thyroid cancer and undetectable thyroglobulin (Tg) and Tg antibodies during ablation.
Phan HT; Jager PL; van der Wal JE; Sluiter WJ; Plukker JT; Dierckx RA; Wolffenbuttel BH; Links TP
Eur J Endocrinol; 2008 Jan; 158(1):77-83. PubMed ID: 18166820
[TBL] [Abstract][Full Text] [Related]
18. Significance of Low Levels of Thyroglobulin Autoantibodies Associated with Undetectable Thyroglobulin After Thyroidectomy for Differentiated Thyroid Carcinoma.
Latrofa F; Ricci D; Sisti E; Piaggi P; Nencetti C; Marinò M; Vitti P
Thyroid; 2016 Jun; 26(6):798-806. PubMed ID: 27020734
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of thyroglobulin antibody epitopes in differentiated thyroid cancer.
Lupoli GA; Okosieme OE; Evans C; Clark PM; Pickett AJ; Premawardhana LD; Lupoli G; Lazarus JH
J Clin Endocrinol Metab; 2015 Jan; 100(1):100-8. PubMed ID: 25322272
[TBL] [Abstract][Full Text] [Related]
20. Stimulated thyroglobulin and pre-ablation antithyroglobulin antibody products can predict the response to radioiodine therapy of TgAb-positive differentiated thyroid cancer patients: a retrospective study.
Han N; Lu C; Li J; Wang C; Zhao Z; Zhang Y; Liu X; Si Z; Wang G; Wang Z; Li F; Wang X
Front Endocrinol (Lausanne); 2023; 14():1222470. PubMed ID: 37810895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
